BAC
Bank of America Corporation
BAC's outlook is improving, though it still trails on the overall score.
RGA
Reinsurance Group of America, Incorporated
RGA has the edge over BAC overall, supported by stronger valuation and stronger fundamentals.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
RGA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
RGA's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like RGA.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over RGA in the historical PE scenario, which offers more potential upside but is not a forecast.
RGA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 9.1x | $274 | — |
| Cheap | 11x | $272 | -0.6% |
| Current | 11x | $274 | — |
| Fair | 14x | $353 | +29% |
| Expensive | 18x | $454 | +66% |
Historical ranges are pointers, not guarantees.
RGA's PE is in its cheap range at 11x. If earnings grow as analysts expect, today's price would be 9.1x next year's earnings.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
RGA Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for RGA, with profitability improving.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
RGA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.01 | +16% |
| Q3 2026 | $25.88 | +99% |
| Q2 2026 | $22.77 | +98% |
| Q1 2026 | $18.46 | +56% |
| Q4 2025 | $17.75 | +65% |
| Q3 2025 | $13.00 | +19% |
| Q2 2025 | $11.52 | -10% |
| Q1 2025 | $11.85 | -7.9% |
| Q4 2024 | $10.74 | -20% |
RGA earned $25.88 per share over the past year, up 99% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over RGA on profitability, with a higher operating margin.
RGA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $7.6B | +22% |
| Q2 2026 | $6.6B | +19% |
| Q1 2026 | $6.5B | +23% |
| Q4 2025 | $6.6B | +27% |
| Q3 2025 | $6.2B | +9.8% |
| Q2 2025 | $5.6B | +15% |
| Q1 2025 | $5.3B | -17% |
| Q4 2024 | $5.2B | +4.7% |
RGA's revenue has grown year over year for six quarters in a row: $7.5B last quarter, up 22% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.3% | +3.1 points |
| Q2 2026 | 9.1% | +3 points |
| Q1 2026 | 6.8% | -0.2 points |
| Q4 2025 | 7.7% | +3.4 points |
| Q3 2025 | 5.2% | +1.4 points |
| Q2 2025 | 6.1% | +0.6 points |
| Q1 2025 | 7% | +2.7 points |
| Q4 2024 | 4.3% | +1 points |
RGA's operating margin was 8.3% last quarter, up 3.1 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
RGA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.4B | -$365M |
| Q2 2026 | -$484M | +$336M |
| Q1 2026 | -$2.9B | -$1.4B |
| Q4 2025 | $7.3B | -57% |
| Q3 2025 | -$990M | +$77M |
| Q2 2025 | -$820M | +$147M |
| Q1 2025 | -$1.4B | +$4.3B |
| Q4 2024 | $17.1B | +150% |
RGA has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over RGA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
RGA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | -1.5% | -1M shares |
| 3 years | -1.5% | -1M shares |
| 5 years | -2.9% | -2M shares |
| Available history | +3.3% | +2.1M shares |
RGA has 66M diluted shares, down 1.5% from a year ago, with $289M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $82M |
| Q2 2026 | $52M |
| Q1 2026 | $94M |
| Q4 2025 | $61M |
| Q3 2025 | $75M |
| Q2 2025 | — |
| Q1 2025 | $38M |
| Q4 2024 | $1M |
RGA spent $289M buying back its own shares over the past year, up 154% from the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
RGA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2021 | 0.5x | Very low |
| Q4 2020 | 0.3x | Very low |
| Q3 2020 | 0.4x | Very low |
| Q2 2020 | -0.9x | Net Cash |
| Q1 2020 | 0.2x | Very low |
| Q4 2019 | 1.3x | Healthy |
RGA's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like RGA.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
RGA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 73.2 | Overbought |
| Stochastic | 81.8 | Overbought |
RGA's weekly RSI is 73 (overbought) and its Stochastic is 82 (overbought).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
RGA PE vs Financial Services Sector
| Metric | RGA | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 19% below |
| PE % | 17 | 63 | 46 pts below |
RGA has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
RGA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $260.6 | 5% above |
| 20 week MA | $249.4 | 9.8% above |
| 50 week MA | $224.0 | 22% above |
| 100 week MA | $210.2 | 30% above |
| 200 week MA | $191.9 | 43% above |
RGA has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
RGA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $162.0 | $113.6 | -30% |
| 2021 | $113.6 | $109.4 | -3.6% |
| 2022 | $109.4 | $142.7 | +30% |
| 2023 | $142.7 | $161.8 | +13% |
| 2024 | $161.8 | $211.4 | +31% |
| 2025 | $211.4 | $205.6 | -2.8% |
| 2026 YTD | $205.6 | $273.7 | +33% |
RGA has the edge over BAC on returns for 2026, with the stronger performance.